Adjuvant high-dose interferon revisited.
Sondak
V K
VK
University of Michigan Comprehensive Cancer Center, Ann Arbor 48109-0932, USA.
Flaherty
L E
LE
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins; D013997:Time Factors
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins